FRANCISCO JOSÉ TINAHONES MADUEÑO – ENSAYO CLINICO COMERCIAL – ASTRAZENECA AB
A Phase 2b Multicentre, Randomised, Double-Blind, PlaceboControlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety and Tolerability of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease with Estimated Glomerular Filtration Rate (eGFR) Between 20 and 60 mL/min/1.73 m2 (Zenith-CKD)
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - A-02 | 0 comments